182 related articles for article (PubMed ID: 28621229)
41. Yeast
Siswanto FM; Tamura A; Sakuma R; Imaoka S
Mol Pharmacol; 2022 Apr; 101(4):257-273. PubMed ID: 35193967
[TBL] [Abstract][Full Text] [Related]
42. Mazes of Nrf2 Regulation.
Zenkov NK; Kozhin PM; Chechushkov AV; Martinovich GG; Kandalintseva NV; Menshchikova EB
Biochemistry (Mosc); 2017 May; 82(5):556-564. PubMed ID: 28601065
[TBL] [Abstract][Full Text] [Related]
43. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
O'Connell MA; Hayes JD
Biochem Soc Trans; 2015 Aug; 43(4):687-9. PubMed ID: 26551713
[TBL] [Abstract][Full Text] [Related]
44. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
45. Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1.
Khan H; Killoran RC; Brickenden A; Fan J; Yang D; Choy WY
Biochem J; 2015 Apr; 467(1):141-51. PubMed ID: 25582950
[TBL] [Abstract][Full Text] [Related]
46. Emerging roles of Nrf2 signal in non-small cell lung cancer.
Tian Y; Liu Q; He X; Yuan X; Chen Y; Chu Q; Wu K
J Hematol Oncol; 2016 Feb; 9():14. PubMed ID: 26922479
[TBL] [Abstract][Full Text] [Related]
47. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
48. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.
Soares MA; Cohen OD; Low YC; Sartor RA; Ellison T; Anil U; Anzai L; Chang JB; Saadeh PB; Rabbani PS; Ceradini DJ
Diabetes; 2016 Mar; 65(3):633-46. PubMed ID: 26647385
[TBL] [Abstract][Full Text] [Related]
49. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.
Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH
Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529
[TBL] [Abstract][Full Text] [Related]
50. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
Hu L; Miao W; Loignon M; Kandouz M; Batist G
Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
[TBL] [Abstract][Full Text] [Related]
51. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
52. Activation of Nrf2 in defense against cadmium-induced oxidative stress.
He X; Chen MG; Ma Q
Chem Res Toxicol; 2008 Jul; 21(7):1375-83. PubMed ID: 18512965
[TBL] [Abstract][Full Text] [Related]
53. DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer.
Zhang Q; Zhang ZY; Du H; Li SZ; Tu R; Jia YF; Zheng Z; Song XM; Du RL; Zhang XD
Cell Death Differ; 2019 Nov; 26(11):2300-2313. PubMed ID: 30778200
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
55. E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells.
Kim WD; Kim YW; Cho IJ; Lee CH; Kim SG
J Cell Sci; 2012 Mar; 125(Pt 5):1284-95. PubMed ID: 22302998
[TBL] [Abstract][Full Text] [Related]
56. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
57. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
Pan PK; Qiao LY; Wen XN
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
[TBL] [Abstract][Full Text] [Related]
58. Carbon disulfide activates p62-Nrf2-keap1 pathway in rat nerve tissues.
Wang S; Chen Y; Kou R; Wang Y; Zeng T; Xie K; Song F
Toxicology; 2016 Aug; 368-369():19-27. PubMed ID: 27530093
[TBL] [Abstract][Full Text] [Related]
59. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression.
Kabaria S; Choi DC; Chaudhuri AD; Jain MR; Li H; Junn E
Free Radic Biol Med; 2015 Dec; 89():548-56. PubMed ID: 26453926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
